Valentina Baez Sosa, M.D.
Staff Clinician
An official website of the United States government
Here’s how you know
Official websites use .gov
A .gov website belongs to an official government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.
Dr. Valentina Baez Sosa is a physician-scientist and translational research leader with hematology, oncology, and transfusion medicine expertise. She is an Assistant Research Physician in Hematology at the National Heart, Lung, and Blood Institute (NHLBI) and a Core Faculty Member in the Hematology-Oncology Fellowship Program. She also leads the Office of Translational Science (OTS), focusing on research development for the Division of Intramural Research (DIR). Board-certified in Internal Medicine, Hematology, Oncology, and Transfusion Medicine & Cellular Therapy, she actively provides patient care on the hematology consult and transplant services.
Her research focuses on advancing cellular therapies and understanding immune effector cell toxicities, with a particular interest in in vivo gene therapy, adoptive cell therapy, and transfusion medicine. Dr. Baez Sosa received her M.D. with magna cum laude from Universidad Central de Venezuela. She completed her internal medicine residency at MedStar Georgetown University Harbor Hospital Center, where she served as Chief Resident; her hematology-oncology fellowship at MedStar Georgetown University Washington Hospital Center, where she was Chief Fellow; and a clinical fellowship in transfusion medicine and cellular therapy at the NIH Clinical Center. She is a dedicated mentor and educator committed to training the next generation of physician-scientists while driving high-impact translational research to improve patient outcomes.
Impact of HLA Alloimmunization on Clinical Outcomes of SAA Treated with Immunosuppressive Therapy
Early Mortality Benefit with COVID-19 Convalescent Plasma: A Matched Control Study
Clearance of Hepatitis C Virus (HCV) Is Associated with Improved Outcomes in HCV-Associated Lymphoma
Uncontrolled Recurrent Myasthenia Gravis Exacerbations Secondary to Chronic Gabapentin Use